{
    "organizations": [],
    "uuid": "357879f762e04d4bee6c13bb1d84fb9700ac56aa",
    "author": "",
    "url": "https://www.reuters.com/article/avexis-ma-novartis/novartis-ag-to-buy-avexis-inc-for-8-7-billion-idUSL3N1RM1CO",
    "ord_in_thread": 0,
    "title": "Novartis AG to buy AveXis Inc for $8.7 billion",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9, 2018 / 4:59 AM / Updated 42 minutes ago Novartis AG to buy AveXis Inc for $8.7 billion Reuters Staff 1 Min Read \nApril 9 (Reuters) - Swiss drugmaker Novartis AG will buy U.S. gene therapy company AveXis Inc for $8.7 billion in cash, the companies said on Monday. \nThe $218-per-share offer represents a premium of 88 percent to AveXisâ€™ Friday close. (Reporting by Kanishka Singh in Bengaluru; Editing by Gopakumar Warrier)",
    "published": "2018-04-09T07:58:00.000+03:00",
    "crawled": "2018-04-09T08:13:05.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "updated",
        "minute",
        "ago",
        "novartis",
        "ag",
        "buy",
        "avexis",
        "inc",
        "billion",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "swiss",
        "drugmaker",
        "novartis",
        "ag",
        "buy",
        "gene",
        "therapy",
        "company",
        "avexis",
        "inc",
        "billion",
        "cash",
        "company",
        "said",
        "monday",
        "offer",
        "represents",
        "premium",
        "percent",
        "avexis",
        "friday",
        "close",
        "reporting",
        "kanishka",
        "singh",
        "bengaluru",
        "editing",
        "gopakumar",
        "warrier"
    ]
}